Contact us (is on the right)

  1. Company
    1. About
    2. Services
  2. Media
    1. News blog
    2. Meet GCT team
  3. White papers
    1. Region and countries
    2. Therapeutic areas
  4. Services
    1. Site registration
    2. Patient information Center
  5. Website information
    1. Privacy policy
    2. Terms of service
    3. Site map
    4. Employees login

Get in touch

Call us:

Email: info@gctrials.com

Meet us at upcoming industry events

More: Offices, Career at GCT

Patients: Patient information Center

About

 

Global Clinical Trials, LLC (“GCT”) is a well-established CRO providing clinical development services for drugs and medical devices since 2001, headquartered in Princeton, NJ, US, and operationally focused on Central-Eastern Europe and Russia.
Currently employing over 60 people and led by a management team with 50+ years of combined clinical trials experience, GCT has 7 local offices across 9 countries and continues to expand its geographical coverage each year.

History

  • 2001
    • An office in St.Petersburg, Russia, is established
    • GCT initiates a first local clinical trial
  • 2003
    • US headquarters opened in Princeton, NJ
  • 2006
    • Clinical operations office in Bulgaria established
    • GCT becomes an exclusive partner of “The White Nights” international ophthalmology congress in CIS
  • 2007
    • New offices in Ukraine and Romania are set up
  • 2008
    • FDA inspectors visit GCT facilities in Russia while examining investigative sites participating in a GI phase III project; no major findings reported
  • 2011
    • Expansion to Hungary and Czech Republic
  • 2012
    • GCT supports a first Russian government-sponsored pharmaceutical clinical
      development program
  • 2015
    • GCT Ukrainian office successfully passes a regulatory inspection by local authority (Ministry of Health)
  • 2016
    • Expansion to Slovak Republic
    • New office in Budapest opened
    • GCT Russian office successfully passes a regulatory inspection by local authority (Federal Healthcare Surveillance Service)

Mission

Our priority is to provide our clients with the highest quality of clinical data in the shortest period of time while making the most of the opportunities offered by CEE region: loyal and interested patient population, motivated investigators, local legislation aligned with international standards, and competitive pricing.

We wish to unlock the region’s potential both for local and international Sponsors and thus offer our unparalleled expertise in cooperating with the national regulatory authorities, tackling logistical aspects of the trials, and ensuring strong project management throughout study execution.

See also

Worldwide coverage